Consolidation period of 18 months no better at promoting off-treatment durability in HBeAg-positive chronic hepatitis B patients with tenofovir disoproxil fumarate treatment than a 12-month period: A prospective randomized cohort study. [electronic resource]
Producer: 20200514Description: e19907 p. digitalISSN:- 1536-5964
- Adult
- Alanine Transaminase -- blood
- Antiviral Agents -- administration & dosage
- Drug Administration Schedule
- Female
- Hepatitis B e Antigens -- blood
- Hepatitis B virus -- drug effects
- Hepatitis B, Chronic -- drug therapy
- Humans
- Male
- Middle Aged
- Prospective Studies
- Recurrence
- Seroconversion -- drug effects
- Sustained Virologic Response
- Tenofovir -- administration & dosage
- Time Factors
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial
There are no comments on this title.
Log in to your account to post a comment.